STAT+: FDA efforts to oversee foreign drug manufacturing remain inadequate to ensure safety, analysis finds
STAT
DECEMBER 4, 2023
In the wake of the Covid-19 pandemic, the Food and Drug Administration inspected far fewer domestic and foreign pharmaceutical facilities, even though manufacturing activity did not decline, according to a new analysis. Europe, India, and China, although there was a slight pullback last year in India and China.
Let's personalize your content